Nexviazyme®
Nexviazyme® is used to treat Pompe disease, a rare genetic disease in which the level of an enzyme called acid alfa-glucosidase is missing or is lower than in healthy individuals. This enzyme helps the body control levels of glycogen (a type of carbohydrate).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Sanofi |
CLASS: Enzymes, Metabolic |
PRESCRIBED BY: Cardiologists |
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Every two weeks |
Length of infusion: Up to seven hours |
FOR MORE INFORMATION: |